Severe Generalized Weakness, Paralysis, and Aphasia following Administration of Irinotecan and Oxaliplatin during FOLFIRINOX Chemotherapy

Severe Generalized Weakness, Paralysis, and Aphasia following Administration of Irinotecan and Oxaliplatin during FOLFIRINOX Chemotherapy

Background: Irinotecan is commonly used in combination with oxaliplatin as a component of FOLFIRINOX chemotherapy for several gastrointestinal malignancies. The purpose of this case report is to describe a patient who developed acute paralysis and aphasia while receiving her initial infusion of irin...

Full description

Bibliographic Details
Main Authors: Manisha Chandar, Robert de Wilton Marsh
Format: Article
Language:English
Published: Karger Publishers 2015-03-01
Series:Case Reports in Oncology
Subjects:
Weakness
Dysarthria
Neurologic side effects
Irinotecan
Oxaliplatin
FOLFIRINOX
Paralysis
Aphasia
Online Access:http://www.karger.com/Article/FullText/380849

Internet

http://www.karger.com/Article/FullText/380849

Similar Items